Advanced search
Publication Cover
OncoImmunology Volume 2, 2013 - Issue 9
Submit an article Journal homepage
533
Views
12
CrossRef citations to date
0
Altmetric
Author's View

Mutations in glioblastoma oncosuppressive pathways pave the way for oncomodulatory activity of cytomegalovirus

Todd C Hollon Department of Neurosurgery; University of Michigan Health System; Ann Arbor, MI USA
,
Richard L Price Department of Neurological Surgery; Dardinger Neuro-oncology Center; The Ohio State University Wexner Medical Center; Columbus, OH USA
,
Chang-Hyuk Kwon Department of Neurological Surgery; Dardinger Neuro-oncology Center; The Ohio State University Wexner Medical Center; Columbus, OH USA; Solid Tumor Program at the James Comprehensive Cancer Center; The Ohio State University Wexner Medical Center; Columbus, OH USA
&
E Antonio Chiocca Harvey Cushing Neuro-Oncology Laboratories; Department of Neurological Surgery; Brigham and Women’s Hospital and Dana-Farber Cancer Institute; Harvard Medical School; Boston, MA USACorrespondence[email protected]
Article: e25620 | Received 01 Jul 2013, Accepted 02 Jul 2013, Published online: 09 Jul 2013

References

  • Cobbs CS, Harkins L, Samanta M, Gillespie GY, Bharara S, King PH, et al. Human cytomegalovirus infection and expression in human malignant glioma. Cancer Res 2002; 62:3347 - 50; PMID: 12067971
  • Sampson JH, Mitchell DA. Is cytomegalovirus a therapeutic target in glioblastoma?. Clin Cancer Res 2011; 17:4619 - 21; http://dx.doi.org/10.1158/1078-0432.CCR-11-0992; PMID: 21632859
  • Michaelis M, Doerr HW, Cinatl J. The story of human cytomegalovirus and cancer: increasing evidence and open questions. Neoplasia 2009; 11:1 - 9; PMID: 19107226
  • Price RL, Song J, Bingmer K, Kim TH, Yi JY, Nowicki MO, et al. Cytomegalovirus contributes to glioblastoma in the context of tumor suppressor mutations. Cancer Res 2013; 73:3441 - 50; http://dx.doi.org/10.1158/0008-5472.CAN-12-3846; PMID: 23729642
  • Price RL, Bingmer K, Harkins L, Iwenofu OH, Kwon CH, Cook C, et al. Cytomegalovirus infection leads to pleomorphic rhabdomyosarcomas in Trp53+/- mice. Cancer Res 2012; 72:5669 - 74; http://dx.doi.org/10.1158/0008-5472.CAN-12-2425; PMID: 23002204
  • Brantley EC, Benveniste EN. Signal transducer and activator of transcription-3: a molecular hub for signaling pathways in gliomas. Mol Cancer Res 2008; 6:675 - 84; http://dx.doi.org/10.1158/1541-7786.MCR-07-2180; PMID: 18505913
  • Cancer Genome Atlas Research Network. Comprehensive genomic characterization defines human glioblastoma genes and core pathways. Nature 2008; 455:1061 - 8; http://dx.doi.org/10.1038/nature07385; PMID: 18772890
  • Slinger E, Maussang D, Schreiber A, Siderius M, Rahbar A, Fraile-Ramos A, et al. HCMV-encoded chemokine receptor US28 mediates proliferative signaling through the IL-6-STAT3 axis. Sci Signal 2010; 3:ra58; http://dx.doi.org/10.1126/scisignal.2001180; PMID: 20682912
  • Soroceanu L, Matlaf L, Bezrookove V, Harkins L, Martinez R, Greene M, et al. Human cytomegalovirus US28 found in glioblastoma promotes an invasive and angiogenic phenotype. Cancer Res 2011; 71:6643 - 53; http://dx.doi.org/10.1158/0008-5472.CAN-11-0744; PMID: 21900396
  • Soroceanu L, Akhavan A, Cobbs CS. Platelet-derived growth factor-alpha receptor activation is required for human cytomegalovirus infection. Nature 2008; 455:391 - 5; http://dx.doi.org/10.1038/nature07209; PMID: 18701889

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.